For the Inventor, By the Inventor

Enter assignee name

Rheinfelden, Switzerland

Tillotts Pharma Ag

USPTO Granted Patents = 32

CIPO Patents = 1

EPO Patents = 27

Trademarks = 6

Forward Citations = 619

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Thomas Buser (14 out of 18 patents)

Roberto Carlos Bravo González (11 out of 15 patents)

Felipe José Oliveira Varum (9 out of 9 patents)

4. Esther Maria Furrer (7 out of 8 patents)

5. Abdul Waseh Basit (7 out of 16 patents)

6. Ana Cristina Freire (6 out of 6 patents)

7. Roberto Carlos Bravo Gonzaléz (5 out of 5 patents)

8. Tea Gunde (3 out of 24 patents)

9. Sebastian Meyer (3 out of 17 patents)

10. Felipe Jose Oliveira Varum (3 out of 3 patents)

11. Brian K Evans (3 out of 7 patents)

12. John Rhodes (3 out of 12 patents)

13. Felipe Varum (3 out of 3 patents)

14. Maxim Puchkov (2 out of 6 patents)

15. Daniel Preisig (2 out of 2 patents)

32 patents: Sort by Forward Citations

1. 12419843 - Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization (2025-09-23),

2. 12370147 - Coatable core for a modified release drug formulation (2025-07-29),

3. 12370146 - Method of producing a delayed release drug formulation (2025-07-29),

4. 12215146 - Antibody variants (2025-02-04),

5. 12209122 - Anti-TNF-alpha-antibodies and functional fragments thereof (2025-01-28),

6. 12043663 - Anti-TNF-alpha-antibodies and functional fragments thereof (2024-07-23),

7. 11999781 - Antibody variants (2024-06-04),

8. 11998641 - Modified release coated capsules (2024-06-04),

9. 11826470 - Preparation of solid dosage forms comprising antibodies by solution/suspension layering (2023-11-28),

10. 11717484 - Topical treatment of inflammatory bowel disease using antibodies and fragments thereof (2023-08-08),

11. 11534406 - Delayed release drug formulation (2022-12-27),

12. 11517534 - Delayed release drug formulation (2022-12-06),

13. 11472872 - Antibody variants (2022-10-18),

14. 11266605 - Modified release coated capsules (2022-03-08),

15. 11160762 - Modified release coated capsules (2021-11-02),

Tillotts Pharma AG is a global pharmaceutical company specializing in the research, development, and commercialization of innovative therapies in gastroenterology. With a mission to improve the lives of patients suffering from gastrointestinal disorders, Tillotts Pharma AG is committed to delivering high-quality medications and therapeutic solutions. For more information about their products and research, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

32 Patents

#1 in Rheinfelden

#404 in Switzerland

#20,093 in the World

Rheinfelden, Switzerland

Tillotts Pharma Ag

Forward Citations = 619

34 inventors:

Thomas Buser (14 out of 18 patents)

Roberto Carlos Bravo González (11 out of 15 patents)

Felipe José Oliveira Varum (9 out of 9 patents)

4. Esther Maria Furrer (7 out of 8 patents)

5. Abdul Waseh Basit (7 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…